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Abstract
B cells play a pivotal role in adaptive immune system, since they maintain a delicate balance between recognition and
clearance of foreign pathogens and tolerance to self. During maturation, B cells progress through a series of developmental
stages defined by specific phenotypic surface markers and the rearrangement and expression of immunoglobulin (Ig)
genes. To get insight into B cell proteome during the maturation pathway, we studied differential protein expression in
eight human cell lines, which cover four distinctive developmental stages; early pre-B, pre-B, plasma cell and immature B cell
upon anti-IgM stimulation. Our two-dimensional differential gel electrophoresis (2D-DIGE) and mass spectrometry based
proteomic study indicates the involvement of large number of proteins with various functions. Notably, proteins related to
cytoskeleton were relatively highly expressed in early pre-B and pre-B cells, whereas plasma cell proteome contained
endoplasmic reticulum and Golgi system proteins. Our long time series analysis in anti-IgM stimulated Ramos B cells
revealed the dynamic regulation of cytoskeleton organization, gene expression and metabolic pathways, among others. The
findings are related to cellular processes in B cells and are discussed in relation to experimental information for the proteins
and pathways they are involved in. Representative 2D-DIGE maps of different B cell maturation stages are available online at
http://structure.bmc.lu.se/BcellProteome/.
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Introduction
B cells play a pivotal role in adaptive immune system, since they
are needed to maintain a delicate balance between recognition
and clearance of foreign pathogens and tolerance to self. During
their maturation, B cells progress through a series of developmen-
tal stages defined by specific phenotypic surface markers and the
rearrangement and expression of immunoglobulin (Ig) coding
genes (for review see [1]). The maturation begins in bone marrow
and foetal liver, and proceeds through ordered series of steps
resulting in the release of immature B cells expressing surface IgM.
These cells exit to periphery and migrate into spleen where they
develop into mature B cells expressing surface IgM and IgD. Only
a minority of the newly generated immature B cells enters the pool
of mature B cells. The majority undergoes apoptosis by
mechanisms, which prevent production of self-recognizing mole-
cules. Once activated, following engagement of B cell antigen
receptor (BCR) with antigen, mature B cells move to germinal
centres in the lymphoid tissue and, with help of other cells,
differentiate into antibody-secreting plasma or memory B cells.
The BCR structure and the signalling pathways following
antigen binding are extensively studied (reviewed in [2], [3]).
Briefly, the BCR consists of the membrane-bound Ig and
depending on the stage of B cell differentiation, it is associated
with a couple of transmembrane proteins, most notably Ig-a and –
b [4]. BCR crosslinking via antigen engagement activates tyrosine-
phosphorylation signalling pathways inside the cell. The phos-
phorylation of immunoreceptor tyrosine activation motifs in Ig-ab
by Lyn initiates the formation of an assembly of intracellular
signalling proteins such as Syk, Bruton tyrosine kinase (Btk) and
Vav. Together with adapter proteins, the assembly regulates
down-stream signalling cascades including the mobilization of
Ca2+ ions, the reorganization of cytoskeleton architecture, the
activation of nuclear transcription factors and the induction of
gene expression. Alterations to proteins and genes involved in the
maturation cause primary immunodeficiencies (PIDs) [5]. These
variations result in defective or aberrant B cell function and
development. Either the development is impaired or the B cells
generated fail to respond to T cell signals [6], [7]. Well over 150
PID-related genes and thousands of PID-causing variations have
been identified [8]. PID patients have increased susceptibility to
recurrent and persistent infections. Early antibiotic treatment and
lifelong immunoglobulin replacement therapy is required for
many patients.
What happens in the B cell proteome during maturation?
Which proteins are co-expressed and what intracellular processes
are activated or silenced? These questions are still largely
unanswered despite extensive studies of individual genes and
proteins (reviewed [9], [10]). To address the question, we analysed
B cell proteomes all the way from early pre-B cell stage until
terminally differentiated plasma cell stage with combined two-
dimensional differential gel electrophoresis (2D-DIGE) and
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matrix-assisted laser desorption/ionization-time of flight-mass
spectrometry (MALDI-TOF-MS). This approach allows proteome
wide analysis of intracellular proteins.
Bioinformatic analysis of nearly 190 proteins revealed signifi-
cant changes in functions of co-expressed proteins between
maturation stages. Notably, cytoskeleton and ontogeny related
proteins were moderately expressed in early pre-B/pre-B cell
stages and silenced at immature B cell (IM-B) stage. The transition
from pre-B to IM-B stage changed significantly the proteome
profile, since proteins from a variety of functional gene ontology
(GO) categories appeared. Our long time series analysis in anti-
IgM stimulated Ramos B cells revealed the dynamic regulation of
cytoskeleton, gene expression and metabolic pathways, among
other cellular events. In plasma cell stage, the proteome contained
endoplasmic reticulum (ER)/Golgi –system proteins needed for
efficient antibody production. The results provide new proteome
wide insights into B cell development and expand our previous
transcriptomic and proteomic studies for anti-IgM stimulated
Ramos B cells [11], [12], [13], [14], [15].
Materials and Methods
Cell Culture and Treatment
Nalm-1, Nalm-6, 380, 697, Ramos and U-266 cell lines were
purchased from Leibniz Institute DSMZ-German Collection of
Microorganisms and Cell Cultures. REH [16], Nalm-1 [17],
Nalm-6 [18], 380 [19], 697 [20], Ramos [21] and U-266 [22] cells
were cultured in RPMI 1640 medium, whereas RS4;11 [23] was
cultured in a-MEM medium (for details about the cell lines see
Table S1). All culture media were supplemented with 10–20%
fetal bovine serum, 100 mg/ml streptomycin and 100 IU/ml
penicillin. For BCR stimulation, Ramos cells were pelleted and
suspended in RPMI culture medium supplemented with 25 mM
HEPES (pH 7.4) and anti-human IgM (20 mg/ml Sigma I2386).
Ramos cells were stimulated or left untreated for 1, 2, 4, 9, 12, 16,
24, 48, 72, 96 and 120 h. Stimulation and incubation were
stopped by adding three volumes of ice-cold phosphate-buffered
saline (PBS) containing protease inhibitors (Complete Protease
Inhibitor Cocktail, Roche) and phosphatase inhibitors (1 mM
sodium orthovanadate and 20 mM sodium fluoride). Two parallel
biological samples of stimulated and control Ramos cells were
prepared for each time point and three parallel samples were
prepared for the other B cells. All cells were washed in ice-cold
PBS containing inhibitors for proteases and phosphatases, pelleted
and stored at 270uC until used.
Protein Sample Preparation
B cell aliquots (about 56107 cells) were lysed in 200–650 ml of
lysis buffer (8 M urea, 4% CHAPS, 30 mM Tris (pH 8.5)
including protease inhibitors) for 30 minutes on ice. The protein
concentration was determined using the DC Protein Assay as
described by the manufacturer (Bio-Rad). An equal volume of ice-
cold sample buffer (2 M thiourea, 7 M urea, 4% CHAPS, 30 mM
Tris (pH 8.5) and protease inhibitors) was added on samples after
protein concentration determination. Soluble proteins were
separated by ultracentrifugation at 100 0006g for 35 min at 4uC.
2D-DIGE and Image Acquisition
Protein samples were labelled with CyDye DIGE Fluor minimal
Cy2-, Cy3- and Cy5-dyes and prepared according to the
manufacturer’s protocol (GE Healthcare). Briefly, 50 mg of each
protein extract was separately labelled with 400 pmol of Cy3- and
Cy5-dyes dissolved in DMF on ice for 30 min. A pooled internal
standard sample was prepared by combining protein extracts from
the eight different B cell lines and labelled with Cy2-dye as above.
The labelling reactions were quenched by the addition of 1 ml of
10 mM L-lysine solution for 10 min. Prior to isoelectric focusing
(IEF), labelled protein samples were added to an equal volume of
DIGE sample buffer (7 M urea, 2 M thiourea, 4% CHAPS,
130 mM dithiotreitol, 2% IPG buffer 3–10 (GE Healthcare)) and
left on ice for 10 min. The Cy2-, Cy3- and Cy5-dye labelled
protein samples to be separated in the same gel were mixed and
rehydration buffer (7 M urea, 2 M thiourea, 4% CHAPS, 13 mM
dithiotreitol, 1% IPG buffer 3–10) was added to obtain a final
volume of 450 ml. The proteins were separated by IEF and
subsequently by 12% SDS-polyacrylamide gel electrophoresis as
described previously [15]. The IEF was carried out using
immobilized nonlinear pH gradient 3–10 gel strips (24 cm
Immobiline DryStrip gels, GE Healthcare) and Ettan II IPGphor
system (GE Healthcare) for a total of 40–50 kVh. The second
dimension protein separation was carried out for 10 h at a
constant wattage of 5 W per gel using Ettan DALTsix electro-
phoresis system (GE Healthcare).
For a statistical analysis of the B cell proteins, two parallel
biological samples were prepared for each B cell line and time
point using a dye-swap design to account for difference arising
from dye-specific effects [24]. Altogether 31 2D-DIGE gels were
prepared and analysed. For preparative gels, 180 mg of unlabelled
protein per sample were applied into gel strips and 2D-gel
electrophoresis (2D-GE) was performed as previously [15].
Proteins were post-stained with silver using a method compatible
with the identification of proteins by mass spectrometry (MS) [25].
The Cy-dye labelled proteins in 2D-DIGE gels were visualized
using a Typhoon Trio scanner (GE Healthcare). The Cy2-labelled
protein map images were scanned using a 488 nm laser and an
emission filter of 520 nm with a band-pass of 40 nm (520BP40),
Cy3 images using a 532 nm laser with a 580BP30 filter and Cy5
images using a 633 nm laser with a 670BP30 filter.
Protein Identification
Prior to identification, the silver stained proteins were in-gel
alkylated and digested with trypsin (Sequencing Grade Modified
Trypsin V5111, Promega) overnight at 37uC using a method
adapted from Shevchenko et al. [26]. The recovered peptides
were, after desalting using mC18 ZipTip (Millipore), subjected to
MALDI-TOF-MS analysis. The proteins were identified using
peptide mass fingerprinting (PMF) followed by database searches.
For unreliable identifications, the protein identities were con-
firmed by fragment ion analysis. MALDI-TOF mass spectra for
PMF and MALDI-TOF/TOF mass spectra for identification by
fragment ion analysis were acquired using an Ultraflex TOF/TOF
instrument (Bruker Daltonik), equipped with a 337 nm UV
nitrogen laser, in a reflector ion mode using a-cyano-4-hydro-
xycinnamic acid as a matrix. The instrument was externally
calibrated using a standard mixture of peptides from Bruker.
Protein identification with the generated mass spectra data was
performed using the Mascot Peptide Mass Fingerprint and MS/
MS Ion Search programmes (Matrix Science). Mascot (V2.3.0.1)
was used as a search engine against SwissProt (v Swis-
sProt_2010_06.fasta) and NCBInr (20100816) databases with
64990 and 845292 mammalian sequences, respectively. Generated
MS spectra were matched with a peptide mass tolerance of
100 ppm and fragment mass tolerance of 0.8 Da. One miss
cleavage was permitted. Carbamidomethylation of Cys was
selected as a fixed modification and oxidation of Met as a variable
modification.
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2D-DIGE Data Analysis
Intra- and inter-gel analyses for the 31 gels were carried out in
DeCyder DIA (differential in-gel analysis) and BVA (biological
variation analysis) modules, respectively (V6.5 GE Healthcare).
After setting manual landmarks, gel-to-gel matching was per-
formed in automatic mode. Protein spot matches were confirmed
and mismatched spots were corrected manually. The normalized
spot volume data of the 89 images (corresponding to 31 gels, since
for certain gels only Cy3 or Cy5 image was used along with Cy2
standard image) were exported for further processing. The
standardized volume ratios for the detected protein spots were
calculated by dividing each normalized spot volume by its
respective in-gel Cy2 internal standard volume and transformed
logarithmically. Analysis of this data set consisted of three steps.
First, the data was subjected to unsupervised cluster and scatter
plot analyses for reproducibility evaluation of the biological
replicates. Second, the averaged spot volumes were calculated
for each protein and two-way hierarchical clustering and paired
correlations were applied across the dataset. Third, to study
proteins affected by the BCR stimulation, the 11 groups of anti-
IgM stimulated Ramos B cells were compared to the correspond-
ing control groups (1, 2, 4, 9, 12, 16, 24, 48, 72, 96 and 120 h),
each group consisting of two biological replicates. The DeCyder
BVA module was used to calculate average abundance changes
and paired student’s t-test p-values for the variance of these ratios
for each protein-pair across stimulated and control groups. Protein
spots that exhibited at least a two-fold decrease or increase in
relative protein volume and p-values #0.05 were considered as
interesting and majority of them were identified by MS analysis.
Identified proteins were matched to their corresponding UniProt
entries using Blast. In the average linkage clustering, the
uncentered correlation distance was used as a similarity metric.
The protein abundance data was clustered using R (V2.1) (www.r-
project.org) and Gene Cluster 2.11 [27] and the results were
visualized using TreeView 1.60 (http://rana.lbl.gov/
EisenSoftware.htm). The protein abundance profiles (1362–1827
protein spots across the cell lines) were investigated by a
correlation matrix. Bivariate Pearson correlations were calculated
using the SPSS (V17.0) software (Softonic).
Bioinformatic Analysis for Differentially Expressed
Proteins
To study B cell maturation stage related protein expression, the
data was filtered to retain only those protein spots, whose volume
changed two-fold or more with relation to internal standard in at
least one cell line or time point. Out of the 836 proteins that passed
the criteria, 174 were identified, grouped into hierarchical clusters
and exposed to GO term [28] enrichment analysis followed by
KEGG [29], BioCarta (http://www.biocarta.com) and Reactome
[30] pathway analyses. Two-way hierarchical clustering algorithm
based on the average linkage method was used to group the
identified proteins. To follow the BCR–activation induced
proteomic changes on time, the differences in relative protein
volumes between anti-IgM stimulated and corresponding control
Ramos B samples were calculated for the 69 identified proteins
that passed the significance criteria (two-fold change in relative
protein abundance with student’s t-test p-value #0.05). The
proteins were clustered on the basis of the differential protein
abundance and exposed to functional annotation analysis. The
clustering results were visualized using TreeView.
To find significant shared GO terms within the clusters of co-
expressed proteins, p-values were calculated using hypergeometric
distribution. The calculations were performed using Gene Set
Analysis Toolkit V2 [31] and the entire dataset (233 identified
proteins encoded by 168 GO-annotated genes, Table S2) was set
as a background for calculations. Criteria for the significance were
that at least two proteins in a cluster share a GO term with p-value
#0.05 adjusted by the Benjamini multiple test adjustment. If the
same set of proteins were significantly enriched in both a parent
and its child term, only the child was listed. The signalling
pathway analyses were run using David V6.7 [32], and for the
significance calculations human genome was set as a background.
Exhaustive literature mining was performed to study biological
roles of the proteins in B cell development.
Results
Proteome wide changes during the maturation of B cells from
early pre-B cell stage until plasma cell stage were investigated using
2D-DIGE and MALDI-TOF-MS based proteomics. This ap-
proach makes use of the Cy-dye technology in the analysis of
differential protein expression permitting greater confidence
compared to the traditional 2D-GE. The proteomic changes were
investigated across eight human cell lines, which together cover
four distinctive differentiation stages in the maturation pathway
(see Figure 1). Further, to study proteins affected by BCR
activation, the proteome profiles of anti-IgM stimulated and
control Ramos B cells were compared in a time series 1–120 h.
Determination of protein expression patterns at each stage
provides information about regulation of cellular processes, such
as Ig chain production, during these stages.
B Cell Proteomes
DeCyder DIA analysis of the 31 gels resulted in detection and
quantitation of 1951–2467 protein spots per gel. A reference gel of
Cy2-labelled internal standard sample with 2063 spots was used as
master gel for DeCyder BVA analysis (Figure 2). BVA analysis
resulted in matching of 1213–1702 spots across the gels and
matching of 1599–1827 spots (78–89%) across the cell lines. The
reproducibility of the protein abundance profiles of biological
replicates was evaluated by scatter plot and unsupervised analyses.
Two independent 2D-DIGE separations of each protein extract
separately labelled with Cy3- and Cy5-dyes were performed, and
the correlation of relative spot intensity (Cy3/Cy2 vs. Cy5/Cy2)
was examined. The Pearson correlation coefficient for all pairs of
biological replicates was 0.6–0.8.
B Cell Proteome Database
Interactive B cell proteome database contains representative
2D-DIGE maps of each maturation stage and information about
the protein identifications. The 233 protein sample spots (SSP) are
numbered in the gel image (Figure 2) and listed in Table S2 with
Mascot scores to show the reliability of the identifications
(p,0.05). The database contains 125 new identifications based
on PMF or by combined PMF and fragment ion analysis in
addition to previous identifications from 2D-GE Ramos dataset
[15]. The peptides identified from different proteins by fragment
ion analysis are listed in Table S3. The database is available online
at http://structure.bmc.lu.se/BcellProteome/.
B Cell Proteomes Cluster According to their Maturation
Stage
In unsupervised analyses, the datasets clustered into maturation
stage related groups with distinctive pattern of Ramos B samples
(Figure 3, Figure S1 and Figure S2). The IM-B Ramos cells
clustered according to time and were distinct from the other cells.
The plasma cell U-266 distinguished from the early pre-B (380,
REH and RS4;11) and pre-B cells (697, Nalm-1 and Nalm-6),
Proteomic Changes During B Cell Maturation
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which showed rather homogenous proteome profiles. The result
reflects the biological similarity of early pre-B and pre-B lineages
(Table S1) and indicates that early during the differentiation
pathway, the proteomes are still close to each other. The
correlation matrix suggests dependencies between protein expres-
sions of consecutive stages, with strongest positive correlation
between successive Ramos B subsets and between early pre-B and
pre-B cells (see Figure S1 right). Interestingly, Ramos B cells at late
time points and early pre-B/pre-B cells have weak negative
correlation. The cluster dendrogram shows the high similarity
between stimulated and corresponding control Ramos B pro-
teomes indicating minor anti-IgM stimulation induced changes,
except at 24 h and at the end of the time course (96–120 h) (see
Figure S2). Those changes in protein expression according to time
are shown in detail in Figure 4.
Enriched GO Terms and Signalling Pathways
Filtering of the data and MS analysis resulted in identification of
188 proteins encoded by 131 GO-annotated genes. Of these
identified proteins, 174 were clustered based on the relative
abundance profiles in different B cell lines (Figure 3), whereas 69
were clustered based on the abundance differences between anti-
IgM stimulated and control Ramos B cells in a time series
(Figure 4). Thus, certain proteins are present in both datasets
indicating differential protein expression upon anti-IgM stimula-
tion as well as differential expression between certain maturation
stages (see Table S2). Significant changes in functions of co-
expressed proteins were revealed with greatest differences between
early pre-B/pre-B and IM-B cells (see Figure 5). Bioinformatic
analysis exposed sheared Biological process, Molecular function
and Cellular component GO terms, as well as signalling pathways
in the clusters of co-expressed proteins (Table 1, Table 2, Table 3
and Table S4, respectively). The unsupervised clustering revealed
progressive changes in expressed proteins upon anti-IgM stimu-
lation in Ramos B cells (Figure 4). In the early stage membrane-
cytoskeleton linked proteins were regulated followed by the
expression of many downstream components, like FAS pathway,
rearrangement of cytoskeleton and initiation of gene expression in
24 hour. The same sets of proteins were re-regulated after 72 h
reflecting the phase in cell division cycle. In the end of the time
course, metabolic proteins were down-regulated indicating
decreased energy requirement and cell death in Ramos B cells.
Discussion
Numerous previous studies have revealed the importance and
function of either single or few proteins during B cell maturation
or at certain maturation stages [33], [34], [35], [36], [37], [38].
Here, we performed an extensive proteomic analysis utilizing eight
human B cell lines. These cell lines are widely used and resemble
their normal B cell counterparts, but they do also have certain
characteristics due to the cell line selection (Table S1). Our results
indicate the involvement of 188 proteins encoded by 131 different
genes. Among them 19 genes/proteins (15%) are already known to
be involved in B cell differentiation.
Immunity and Cytoskeleton Associated Proteins are
Regulated during Maturation
Proteins highly or moderately expressed in early pre-B and pre-
B stages clustered into two different clusters (numbered 18 and 13
in Figure 3). The first cluster accommodates six proteins
(eukaryotic translation initiation factor (eIF)-5A-1, Rho-GDP-
dissociation inhibitor 2 (Rho-GDI2), peroxiredoxin-1 (Prdx-1),
RNA helicase DDX39B, heat-shock protein b-1 (HspB1) and
lamin-B1) with various functions and decreased abundance after
pre-B stage (immune response GO:6955, nucleocytoplasmic
transport GO:6913, regulation of translation GO:6417 and
induction of apoptosis GO:6917 in Table 1, and cluster 18 in
Figure 3). The expression of Rho-GDI2 (see Figure 5) and Prdx-1
reached a minimum in plasma cell stage. Interestingly, Prdx-1
(SSP 212 and 213 in Figure 2) and RNA helicase DDX39B (SSP
82 and 83 in Figure 2) clustered not only based on their protein
expression, but also based on their isoelectric point (pI) values
indicating post-translational modification (PTM) specific co-
expression. The second cluster accommodates seven cytoskeleton
linked proteins, namely cofilin-1, profilin-1, tropomyosin a-3 and
Figure 1. PID-related proteins in B cell maturation pathway. Defects in proteins and genes important for maturation cause PIDs and block the
maturation on certain stage. The PID-related proteins and stages where diseases affect the development are shown on top. The cell lines (RS4;11, 380,
REH, 697, Nalm-1, Nalm-6, Ramos and U-266) are marked inside the corresponding cells representing their normal B cell counterparts.
doi:10.1371/journal.pone.0077894.g001
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a-4, vimentin, b-actin and moesin (GO:5200 in Table 2, and
cluster 13 in Figure 3), as well as additional proteins of interest.
Some of these proteins had decreasing expression profile after pre-
B stage, like tropomyosin a-4 and profilin-1, whereas the others
were re-expressed in plasma cell stage, like tropomyosin a-3 and
vimentin (Figure 5). In line with this, vimentin is expressed in
many B cell types except Burkitt lymphoma [39]. Annexin A5
(AnxA5) had an unique expression profile, since it was highly
expressed in early pre-B cells, silenced in pre-B and IM-B
phenotypes and re-expressed in plasma cell type. Annexins bind to
Ca2+-ions and the co-expression of AnxA5/A6 with cytoskeleton
linked proteins (cluster 13 in Figure 3) might be related to Ca2+-
signalling and regulation of membrane-cytoskeleton organization
in early pre-B cells. Variations in cytoskeleton regulators are
associated with the development of antibody deficiency syndromes
in humans indicating their importance during B cell differentiation
[40]. Also in developing chicken B cells, the dynamic regulation of
cytoskeleton linked proteins was shown recently [35].
Although the proteomes of early pre-B and pre-B stages were
highly similar, single proteins like ezrin, moesin, and ubiquitin-like
domain-containing CTD phosphatase 1 (UBLCP1) were differen-
tially expressed between early pre-B and pre-B groups. Moesin was
highly expressed in early pre-B stage (380, REH and RS4;11),
whereas ezrin was not expressed until in pre-B stage (697 and
Nalm-6). Interestingly, ezrin was also regulated in 24 h upon anti-
IgM stimulation (discussed in section: Proteins in different
signalling pathways act together at 24 h), whereas ezrin and
moesin were regulated early upon anti-IgM stimulation in Ramos
B cells [37]. Ezrin and moesin are members of the ezrin-radixin-
moesin family, members of which are involved in signal
transduction to the actin cytoskeleton through Rho GTPases
[41] whereby there is a negative feedback between activation of
moesin and activity of the Rho pathway [42]. UBLCP1 had
interesting yet unique protein abundance profile with decreased
abundance in pre-B stage (697, Nalm-1 and Nalm-6) in relative to
other developmental stages with moderate expression. UBLCP1
dephosphorylates nuclear 26S proteasomes, thereby decreasing
their proteolytic activity [43]. The role of ubiquitin-proteasome
system in respect to immune system is reviewed in [44].
In addition, we identified several proteins known to be regulated
during B or T cell maturation, like DNA mismatch repair protein
Msh2, inosine-59-monophosphate dehydrogenase 2 (IMPD2),
Figure 2. Reference 2D-DIGE map of Cy2-labelled internal standard. The 233 identified proteins are numbered in the gel and listed in Table
S2.
doi:10.1371/journal.pone.0077894.g002
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proliferating cell nuclear antigen (PCNA), Ku80, Ras GTPase-
activating protein-binding protein 1 (G3BP-1), superoxide dis-
mutase 1 (Sod1) and HspB1. The expression of these proteins
reflects many known aspects of B cell ontogeny but also reveals
many novel features. Msh2 and PCNA take part in DNA
mismatch repair (GO:6298) and their protein abundance
decreased after pre-B stage (see Figure 5 and cluster 13 in
Figure 3). The expression of Msh2 and PCNA reached a
minimum in Nalm-6 and 697 cells, respectively. Nalm-6 represents
the most developed pre-B cell in the basis of its membrane m
expression [18]. Msh2 has a special role in B cell differentiation,
since it is needed in somatic hypermutation of Ig genes, which
results in amino acid changes in the rearranged V regions of Ig
[45]. In line with our results, PCNA was highly expressed in mice
pre-B cells [46]. Ku80 and G3BP-1 were moderately expressed in
380 and REH or Nalm-1 cells. G3BP-1 takes part in Ras
signalling, which is essential for pre-B cell development. The
expression of dominant negative Ras blocks development at the
pro-B cell stage [47], whereas the expression of constitutively
active Ras induces developmental progression and IgL recombi-
nation [48]. Ku is a component of DNA non-homologous end
joining machinery, which joins the DNA ends and completes the
V(D)J recombination event [49]. IMPD2 and Sod1 were highly
expressed in pre-B and plasma cells compared to Ramos IM-B
cells (clusters 11 and 17, respectively, in Fig. 3). The importance of
Sod1 and IMPD2 has been shown in T cells [50], [51], but not
previously in B cells. The protein abundance pattern of HspB1
(cluster 18 Figure 3) was in accordance with the maturation stage
of normal B-lineage cells [52].
Transition from Pre-B to IM-B Cell Stage: Striking Changes
in the Proteome Profile
The transition from pre-B to IM-B stage changed significantly
the proteome profile, since proteins in six additional GO
categories appeared. RNA binding (GO:3723 in Table 2),
chromatin modification (GO:16568 in Table 1), mitochondrial
and secretory granule proteins (GO:44429 and GO:30141 in
Table 3) were selectively expressed in IM-B stage (clusters 1 and 3
in Figure 3), whereas the expression of ER and melanosome
proteins (GO:5788 and GO:42470 in Table 3) continued or
increased until plasma cell stage (cluster 8 in Figure 3). The co-
expression of IgM, non-specific lipid-transfer protein, protein
disulfide-isomerase A3 (ERp60), hypoxia up-regulated protein 1
(GRP-170) (GO:5788 and cluster 5 in Table 3) and cytoplasmic
membrane bound vesicle proteins; Hsp60 and HSP90AB1,
indicate active IgM chain production and transport in Ramos
cells (see Figure 5, and cluster 6 in Figure 3). The relatively high
expression of chromobox protein homolog 2 (CBX2), ruvB-like 1/
2 and prohibitin indicate regulation of transcription via chromatin
structure modification (GO:16568 in Table 1, and cluster 3 in
Figure 3). Noticeably, some of these proteins have special functions
in developing B cells, like prohibitin, which interacts selectively
with IgM [53]. RuvB-like 1/2 possesses single-stranded DNA-
stimulated ATPase and ATP-dependent DNA helicase activities
and is a component of the NuA4 histone acetyltransferase (HAT)
complex. NuA4 HAT induces transcriptional activation and open
chromatin structure by acetylating nucleosomal histones [54].
Interestingly, the more acidic isoforms of ruvB-like 1 and 22 (see
Figure 5, and SSP 77 and 89 in Figure 2) were expressed
exclusively in Ramos B cells indicating PTM specific regulation.
CBX2 is a component of the Polycomb group multiprotein PRC1-
like complex, which maintains transcriptionally repressive state of
many genes throughout lymphopoiesis [55]. The reduction of
enzymes involved in nucleotide metabolism and glucose catabo-
Figure 3. Unsupervised clustering of B cell samples on the
basis of protein profiles. IM-B Ramos samples clustered according to
time after anti-IgM stimulation (1–120 h) and were distinctive from early
pre-B (RS4;11, 380 and REH), pre-B (697, Nalm-1 and Nalm-6) and
plasma cell U-266 samples. The degree of similarity in profiles is shown
by colour (base-two logarithmical scale below the figure). Red and
green indicate high and low levels of protein expression in relative to
internal standard. The average protein abundance of the 175 identified
proteins (labelled with Cy3 and Cy5 dyes) is calculated relative to
internal standard (labelled with Cy2 dye). Cluster numbers (1–19) are
shown to the right and refer to those in Table 1, Table 2, Table 3, Table
S2 and Table S4.
doi:10.1371/journal.pone.0077894.g003
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Figure 4. Unsupervised clustering of proteins affected by anti-IgM stimulation. The heat map shows the comparison between anti-IgM
stimulated and control Ramos samples during the time course 1–120 h. Protein abundance difference is calculated between stimulated and
corresponding control samples for the 69 identified proteins, which passed the significance criteria (student’s t-test p#0.05). Red and green colours
indicate up- and down-regulation in response to anti-IgM stimulation (base-two logarithmical scale below the figure). Cluster numbers (1R-11R), short
protein names and SSP are shown to the right and refer to those in Table 1, Table 2, Table 3, Table S2 and Table S4.
doi:10.1371/journal.pone.0077894.g004
Table 1. Biological process GO terms and their p-values for co-expressed proteins.
GO ID GO term Protein (SSP)a) P adj.b) Clusterc)
16570 Histone modification Prohibitin (176) ruvB-like 1 (77, 87) ruvB-like 2 (89, 90) 0.0536 2
16569 Covalent chromatin
modification
Prohibitin (176) ruvB-like 1 (77, 87) ruvB-like 2 (89, 90) 0.0536 2
6119 Oxidative phosphorylation ATP synthase b (93) dihydrolipoyl dehydrogenase
(66) cytochrome b-c1 (101)
0.0536 2
16568 Chromatin modification CBX2 (80) prohibitin (176) ruvB-like 1 (77, 87) ruvB-like 2 (89, 90) 0.0306 3
9117 Nucleotide metabolic Aldolase A (134) dUTPase (215) IDH3A (136) LDH-B (147, 149) malate
dehydrogenase 1 (Mdh1) (151) NDK A (217) phosphoglycerate mutase 1 (187)
PURH (47) transaldolase (137) triosephosphate isomerase (193, 194)
0.0021 15
19362 Pyridine nucleotide
metabolic
IDH3A (136) LDH-B (147, 149) Mdh1 (151) phosphoglycerate mutase
1 (187) transaldolase (137) triosephosphate isomerase (193, 194)
0.0055 15
6007 Glucose catabolic Aldolase A (134) aldolase C (132) a-enolase (95, 104, 105, 106, 110)
LDH-B (147, 149) Mdh1 (151) phosphoglycerate mutase 1 (187)
transaldolase (137) triosephosphate isomerase (193, 194)
0.0055 15
46496 Nicotinamide nucleotide
metabolic
IDH3A (136) LDH-B (147, 149) Mdh1 (151), phosphoglycerate mutase
1 (187) transaldolase (137) triosephosphate isomerase (193, 194)
0.0055 15
6096 Glycolysis Aldolase A (134) aldolase C (132) a-enolase (95, 104, 105, 106, 110)
LDH-B (147, 149) Mdh1 (151) phosphoglycerate mutase 1 (187)
triosephosphate isomerase (193, 194)
0.0093 15
8360 Regulation of cell shape Aldolase A (134) coronin-1A (59) ezrin (21) 0.0499 15
6098 Pentose-phosphate shunt phosphoglycerate mutase 1 (187) transaldolase (137)
triosephosphate isomerase (193, 194)
0.0138 16
6913 Nucleocytoplasmic transport DDX39B (82) eIF-5A-1 (224) Prdx-1 (212) 0.0467 18
6406 mRNA export from nucleus DDX39B (82) eIF-5A-1 (224) 0.0467 18
6417 Regulation of translation eIF-5A-1 (224) HspB1 (197) 0.0534 18
6917 Induction of apoptosis eIF-5A-1 (224) Prdx-1 (212) 0.0534 18
6955 Immune response Rho GDI 2 (206) Prdx-1 (212) 0.0378 19
35308 Negative regulation of protein amino
acid dephosphorylation
14-3-3 b/a (185) 14-3-3 e (172) 0.021 1R
44248 Cellular catabolic Aldolase A (134) a-enolase (103) citrate synthase (118)
mAspAT (129) LDH-B (147, 149) Mdh2 (152)
proteasome a3 (181) Sod1 (220)
0.03 8R
44262 Cellular carbohydrate metabolic Aldolase A (134) citrate synthase (118)
a-enolase (103) LDH-B (147, 149) Mdh2 (152)
0.03 8R
6107 Oxaloacetate metabolic Citrate synthase (118) mAspAT (129) malate dehydrogenase (152) 0.03 8R
6096 Glycolysis Aldolase A (134) a-enolase (103) LDH-B (147, 149) Mdh2 (152) 0.03 8R
30097 Hemopoiesis NDK A (217) Sod1 (220) Ku80 (17) 0.0317 8R
50793 Regulation of developmental process Aldolase A (134) Ku80 (17) NDK A (217) Sod1 (220) 0.0347 8R
46496 Nicotinamide nucleotide metabolic Aldolase A (134) LDH-B (147, 149) Mdh2 (152) NDK A (217) 0.0374 8R
48523 Negative regulation of
cellular process
a-Enolase (103) HspB1 (199) NDK A
(217) SET (125, 139) Sod1 (220) Ku80 (17)
0.045 8R
8152 Metabolic Aldolase A (134) citrate synthase (118) a-enolase (103) HspB1 (199)
Ku80 (17) LDH-B (147, 149) mAspAT (129) Mdh2 (152), NDK A (217)
proteasome a3 (181) SET (125, 139) Sod1 (220)
0.0482 8R
7010 Cytoskeleton organization Cofilin-1 (222) plastin-2 (42, 43) stathmin (219) 0.0487 11R
51261 Protein depolymerization Cofilin-1 (222) stathmin (219) 0.0513 11R
a)SSP referring to those numbers in Figure 2 and short protein names referring to those proteins listed in Table S2.
b)P-value adjusted by the Benjamini multiple test adjustment.
c)Cluster numbers referring to those in Figure 3 and Figure 4.
doi:10.1371/journal.pone.0077894.t001
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lism (GO:9117, GO:6007, cluster 15 in Table 1) indicates reduced
metabolism in Ramos cells at 72–120 h compared to other cell
stages.
Plasma Cell is Specialized in the Expression of ER and Ig
Secretory Machine Proteins
The transition from IM-B to plasma cell stage narrowed the
repertoire in functions of co-expressed proteins. When Ramos cells
express proteins from a variety of functional GO categories, the U-
266 cells are specialized in ER/Golgi system related protein
expression. Among the ER resident proteins, the expression of
ERp5, ERp46 and TXNDC5 continued from IM-B stage to
plasma cell stage, whereas the expression of ERp60 and GRP-170
was silenced in plasma cell stage (cluster 9 and 5, respectively, in
Figure 3). The overlapping but diverse expression of ER and
folding enzymes indicates different mechanism for Ig chain
processing and transport in U-266 and Ramos cells. These
differences likely reflect the different functions and phenotypes of
the IM-B and plasma cells. Ramos B cells express IgM on their cell
surface and secrete it in small amounts, whereas U-266 cells
secrete vast amounts of IgE but lack membrane Ig [22], [56].
Further, gene-expression programs of antigen activated B cells are
different from those of plasma cells (reviewed in [9]).
Proteins elevated in plasma cell clustered into three different
clusters based on their expression patterns across the maturation
pathway. The first cluster (number 8 in Figure 3) contains ER/
Golgi proteins (GO: 5788, GO: 5789, GO: 5793 in Table 3) and
membrane bound vesicle proteins (GO:42470, GO:42598 in
Table 3), which were not expressed until in IM-B stage. For
example, the expression of 78 kDa glucose-regulated protein
(GRP-78) and endoplasmin (GRP-94) was elevated in Ramos B
cells at 48–120 h (see Figure 5), whereas the expression of protein
disulfide isomerase (PDI) reached a maximum in U-266 cells. In
line with this, the requirement of efficient Ig assembly and disulfide
bond isomerization increases during the maturation, as confirmed
by observations of others [57], [58]. The second cluster
accommodates ER proteins (GO:5783 and cluster 9 in Figure 3
and Table 3) and five enzymes with peptidase or isomerase
activity; peptidyl-prolyl isomerase, cytosolic non-specific dipepti-
dase, cytosol aminopeptidase, proteasome subunit a type 7 and
ubiquitin carboxyl-terminal hydrolase isozyme L1. These proteins
were not highly expressed until in terminally differentiated plasma
cell stage, as shown previously in mouse B cells [38], [58].
Interestingly, synaptic vesicle membrane protein VAT-1 clustered
in the same group indicating a possible new function of VAT-1 in
U-266 plasma cells. The third cluster (number 12 in Figure 3)
contains five proteins with U- or J-shaped expression profiles,
namely AnxA5/6, c-enolase, galectin-1 (GAL-1) and melanoma-
associated antigen 4 (MAGE 4). AnxA5/6 had relatively moderate
expression in early pre-B/pre-B cells, negligible in IM-B and high
expression in plasma cell stage. AnxA5 and A6 interact with
phospholipids in the presence of calcium (GO:5544 in Table 2)
and dock onto membrane structures such as Golgi, ER and
vesicles [59], [60]. Since these organelles are elevated in plasma
cells [61], it is not surprising that AnxA5/6 expression was high in
U-266 cells. Like AnxA5/6, c-enolase and VAT-1 are calcium
dependent, and their high expression might be related to ER,
where calcium concentration is high. GAL-1 promotes Ig
production and plasma cell differentiation [62]. In line with our
result, GAL-1 expression is regulated during B cell development
[63]. MAGE 4 may have a role in embryonic development and
tumour progression, but its function is not known indicating its
potential new function in U-266 cells.
Regulation of Signalling Pathways during the Maturation
The correlation matrix suggests reverse expression patterns
between early pre-B/pre-B and activated IM-B Ramos cells at late
time points 48–96 h (see Figure S1 right). The signalling pathway
analysis revealed many proteins with reverse expression between
IM-B and early pre-B/pre-B cells and the pathways they are
involved in (clusters 4, 14, and 15 in Table S4 and Figure 3). Some
of these pathways reflect common cellular metabolic processes
such as DNA replication, cell cycle control and metabolism of
carbohydrate and amino acids (Reactome:383, Reactome:1538,
Reactome:474 and Reactome:13, respectively, Table S4). The
BCR stimulation in Ramos cells strengthened the down-regulation
of many metabolic enzymes compared to resting Ramos cells (see
Reactome:474 and clusters 7R, 4, 14 and 15 in Table S4). The low
expression of these proteins in Ramos cells may simply reflect the
cycling status. Interestingly, Btk was co-expressed with cell cycle
control and DNA replication proteins. For proper BCR signalling,
Table 2. Molecular function GO terms and their p-values for co-expressed proteins.
GO ID GO term Protein (SSP)a) P adj.b) Clusterc)
3723 RNA binding hnRNP C1/C2 (131) 60S ribosomal SA (148, 150) 0.039 1
15075 Ion transmembrane transporter activity ATP synthase b (93) cytochrome b-c1 (101) VDAC-1 (167) 0.0169 2
15078 Hydrogen-ion transmembrane transporter
activity
ATP synthase b (93) cytochrome b-c1 (101) 0.0305 2
5544 Calcium-dependent phospholipids binding AnxA5 (58) AnxA6 (38) 0.0091 12
19901 Protein kinase binding b-Actin (115) phosphoglycerate mutase 1 (187) vimentin (67, 68) 0.0352 14
5200 Structural constituent of cytoskeleton b-Actin (115) moesin (24) vimentin (67, 68) 0.0447 14
50815 Phosphoserine binding 14-3-3 b/a (185) 14-3-3 e (172) 0.0134 1R
42826 Histone deacetylase binding 14-3-3 b/a (185) 14-3-3 e (172) 0.0134 1R
3723 RNA binding eIF-2-a (142) DDX39B (83) G3BP-1 (49) hnRNP
C1/C2 (141), hnRNP K (71) TyrRS (52)
0.032 3R
8092 Cytoskeletal protein binding Cofilin-1 (222) plastin-2 (42, 43) stathmin (219) 0.035 11R
a)SSP referring to those numbers in Figure 2 and short protein names referring to those proteins listed in Table S2.
b)P-value adjusted by the Benjamini multiple test adjustment.
c)Cluster numbers referring to those in Figure 3 and Figure 4.
doi:10.1371/journal.pone.0077894.t002
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ordered activation of protein tyrosine kinases (PTK) Lyn, Syk and
Btk is required. Deficiencies in these PTKs cause defective or
aberrant B cell function and development (see Figure 1) [64], [65],
[66], [67], [68]. In line with our result, genes involved in cell cycle
control, DNA replication, molecular transport and cytoskeleton
structure were highly expressed in mice pre-B cells [46].
The pathway analysis suggest opposite respond in antigen
processing and presentation pathway (KEGG:hsa04612 in Table
S4) in Ramos cells compared to other cells. The first actors in the
antigen processing pathway, namely proteasome activator 28
(PA28)-ab and a core particle of 20S proteasome a3, were
negligibly expressed in Ramos cells whereas the downstream
components, such as metalloprotease component of the 26S
proteasome, ER and secretory granule proteins (albumin, ERp60,
GRP-78, GRP-94, GRP-170, Hsp60 and HSP90AB1), were
highly expressed (see Figure 5). In the other cell types, the
expression of these proteins is reversed suggesting silencing of the
antigen presentation pathway. Interestingly, PA28 and DJ-1 were
co-expressed (cluster 17 Fig. 3) as shown previously [15], [69], but
their possible interaction is not known. In conclusion, many of the
proteins involved act close together in different pathways (see
Table S4) indicating a signalling network, rather than separate
pathways.
Early Events Upon Anti-IgM Stimulation: Regulation of
Cell Membrane-Cytoskeleton
BCR comprises the membrane-bound Ig in association with the
accessory signal transduction components Ig-ab [4]. Upon anti-
IgM stimulation, the components of BCR complex were down-
regulated (IgL l SSP 168 in Figure 4) [13,14] followed by the
regulation of four cytoskeleton related proteins; stathmin, plastin-
2, cofilin-1 and pre-mRNA-processing factor 40 homolog A (HIP-
10) (clusters 4R and 11R in Figure 4, GO:7101 and GO:51261 in
Table 1 and GO:8092 in Table 2). The pI changes in the actin
binding proteins; stathmin, plastin-2 and cofilin-1, interpret
regulation via PTM. In the early stage 1–4 h, plastin-2 (SSP 42,
43 and 45 in Figure 2 and Figure 4), stathmin (SSP 219 and 223 in
Figure 2 and Figure 4) and HIP-10 were regulated followed by the
down-regulation of cofilin-1 at 4–16 h (see Figure 4). Cofilin-1
depolymerizes actin filaments thereby promoting actin turnover.
In line with our results, differential expression of cytoskeleton
associated proteins was recently shown in anti-IgM stimulated
Table 3. Cellular component GO terms and their p-values for co-expressed proteins.
GO ID GO term Protein (SSP)a) P adj.b) Clusterc)
5743 Mitochondrial inner
membrane
ATP synthase b (93) cytochrome b-c1 (101) Hsp60 (54, 55),
prohibitin (176) VDAC-1 (167)
0.0018 2
44429 Mitochondrial part ATP synthase b (93) cytochrome b-c1 (101) dihydrolipoyl
dehydrogenase (66) Hsp60 (54, 55) prohibitin (176) VDAC-1 (167)
0.0059 2
35267 NuA4 HAT complex RuvB-like 1 (77, 87) ruvB-like 2 (89, 90) 0.0441 2
42645 Mitochondrial nucleoid ATP synthase b (93) VDAC-1 (167) 0.0441 2
5759 Mitochondrial matrix ATP synthase b (93) dihydrolipoyl dehydrogenase
(66) Hsp60 (54, 55) VDAC-1 (167)
0.0441 2
30141 Secretory granule Albumin (35, 36) dihydrolipoyl dehydrogenase (66) Hsp60 (54, 55) 0.015 3
5743 Mitochondrial inner
membrane
ATP synthase b (93) cytochrome b-c1 complex 1 (101)
Hsp60 (55, 54) mAspAT (129) prohibitin (176) VDAC-1 (167)
0.0187 4
44429 Mitochondrial part ATP synthase b (93) cytochrome b-c1 complex 1 (101) dihydrolipoyl
dehydrogenase (66) Hsp60 (54, 55) mitochondrial aldehyde dehydrogenase 2
(mAldh2) (75) mAspAT (129) prohibitin (176) VDAC-1 (167)
0.0302 4
31974 Membrane-enclosed
lumen
Albumin (35, 36) mAldh2 (75) ATP synthase b (93) cytochrome
b-c1complex 1 (101) dihydrolipoyl dehydrogenase (66) GRP-78 (25, 26, 27)
GRP-94 (12) GRP-170 (1, 2) Hsp60 (54, 55) mAspAT (129), PDI (60) prohibitin
(176) ruvB-like 1 (77, 87) ruvB-like 2 (89, 90) VDAC-1 (167)
0.032 4
5788 ER lumen ERp60 (62, 63) GRP-170 (1, 2) 0.0407 5
5788 ER lumen ERp60 (62, 63, 64) GRP-78 (25, 26, 27) GRP-94 (12) GRP-170 (1, 2) PDI (60) 0.0004 7
42470 Melanosome ERp60 (62, 64, 63) GRP-78 (25, 26, 27) GRP-94 (12) HSP90AB1 (153) PDI (60) 0.0168 7
5788 ER lumen GRP-78 (25, 26, 27) GRP-94 (12) PDI (60) 0.0011 8
5789 ER membrane GRP-78 (25, 26, 27) GRP-94 (12) 0.0021 8
42470 Melanosome GRP-78 (25, 26, 27) GRP-94 (12) PDI (60) 0.0046 8
5793 ER-Golgi intermediate
compartment
GRP-78 (25, 26, 27) PDI (60) 0.0059 8
42598 Vesicular fraction GRP-94 (12) PDI (60) 0.0105 8
5783 ER Neutral a-glucosidase AB (5, 14) ERp5 (97) SET (125) TXNDC5 (99, 100, 108) 0.0074 10
30529 Ribonucleoprotein
complex
b-Actin (115, 114, 112, 127) eIF-2-a (142) hnRNP C1/C2 (131, 141, 143)
hnRNP K (71) hnRNP Q (116) DDX39B (83) 40S ribosomal protein SA (130)
0.0222 3R, 6R
3167 NuA4 HAT complex b-Actin (121, 122) ruvB-like 2 (89) 0.0017 5R
a)SSP referring to those numbers in Figure 2 and short protein names referring to those proteins listed in Table S2.
b)P-value adjusted by the Benjamini multiple test adjustment.
c)Cluster numbers referring to those in Figure 3 and Figure 4.
doi:10.1371/journal.pone.0077894.t003
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chronic lymphocytic leukaemia (CLL) cells [70]. Rearrangements
in the cytoskeleton play a pivotal role in B cell activation (reviewed
in [71]). Yet, we do not fully understand how the actin-binding
proteins link co-stimulation in the membrane to rearrangements in
the underlying cytoskeleton. In human T cells, plastin-2 and
stathmin are phosphorylated and cofilin-1 is dephosphorylated in
response to co-stimulation through T cell receptor/CD3 and CD2
or CD28, respectively [72], [73], [74], [75].
Downstream from the events related to membrane-cytoskeleton,
Ramos B cells progress to gene expression with few proteomic
changes at 9–16 h: Phosphoglycerate mutase (SSP 184) was down-
regulated at 4–12 h followed by up- and down-regulation of 60 S
acidic ribosomal protein P0 at 9–16 h, as shown previously [15],
[38]. Since the expression of these proteins is isoforms specific, it
suggests regulation of translation via PTM. Further, elongation
factor 1-b (SSP 171) was down-regulated at 16 h.
Proteins from Different Signalling Pathways Act Together
at 24 h
After the relatively quiescent time period around 16 h, a variety
of downstream events occurred at 24 h (see Figure 4). Proteins in
Ras, FAS and cytoskeleton organization pathways were regulated
among others. Many of these proteins are co-expressed also at
72 h (clusters 3R and 6R in Figure 4) reflecting the cell division
cycle in Ramos cells. The regulation of myosin regulatory light
chain 12A, actin, actin-related protein 2/3, PAK-2, ezrin and
Rho-GDI2 indicate cytoskeleton remodelling (KEGG:hsa4810 in
Table S4, clusters 3R, 5R and 6R in Figure 4). The up-regulation
of G3BP-1, Rho-GDI2 and 14-3-3 b/a suggests activation of Ras
pathway (GO:7265) at 24 h. The co-expression of PAK-2, Rho-
GDI2 and lamin-B1 indicate FAS (CD95) signalling (BioCarta:-
fasPathway in Table S4), whereas the co-expression of 14-3-3
protein b/a, lamin-B1, PAK-2 and PA28c indicate apoptosis
(Reactome:578) at 24 h. The apoptosis in Ramos cells reaches a
maximum at 24 h [76], but the mechanism is likely FAS
independent [77], [78], [79]. Our results suggest that BCR
activation is a dynamic network, in which proteins from different
signalling pathways act closely together. Interestingly, proteins co-
expressed at 24 h, namely ezrin, 14-3-3 t and heterogenous
nuclear ribonucleoprotein K (hnRNP K), act also in the very early
phase upon anti-IgM stimulation [37], [80], [81], [82]. Changes in
the phosphorylation status of these proteins are the major
Figure 5. Differences in proteome profiles between IM-B and early pre-B cell stages. Early pre-B 380 and IM-B Ramos (120 h time point)
proteome samples were labelled with Cy5 and Cy3 dyes, respectively, and separated in a 2D-DIGE gel (nonlinear pH gradient 3–10) with internal
standard sample labelled with Cy2 dye. Triple image overlay shows proteins highly expressed in Ramos (red) and 380 (green) samples in relative to
internal standard sample (blue). Protein identities are indicated for those proteins with major changes in expression profile. IgM chains, ER and
membrane bound vesicle proteins were highly expressed in Ramos cells, whereas cytoskeleton and immunity related proteins were expressed in 380
cells.
doi:10.1371/journal.pone.0077894.g005
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regulators of activation. For example, ezrin dephosphorylates in
few minutes upon anti-IgM stimulation and has a conformational
change, which detaches it temporarily from actin and from lipid
rafts [37]. Syk is activated via Tyr-phosphorylation, but recent
studies indicate that Syk is also Ser-phosphorylated at multiple
sites and binds 14-3-3 proteins [80], [81]. Our time scale analysis
suggests that those proteins known to be important in the very
early stages upon BCR stimulation are re-regulated in 24 hours.
The equipment of Ramos B cells with larger quantities of
ribosomal subunits and RNA binding proteins (GO:30529 in
Table 3 and GO:3723 Table 2) indicate active translation at 24
and 72 h (Reactome:71 for gene expression). Trp-tRNA ligase
(TrpRS) and Tyr-tRNA ligase (TyrRS) were up-regulated at 24 h,
whereas eIF-2-a was continuously up-regulated 24–72 h (Figure 4).
EIF-2-a forms a complex with GTP and initiator tRNA at the
early steps of protein synthesis. Interestingly, TrpRS had identical
expression profile with PA28c. The role of PA28c in B-cells is not
clear, although its up-regulation is shown previously in stimulated
B cells indicating its importance in B cell activation [38]. In line
with our results, the regulation of hnRNP proteins (ribonucleo-
protein complex GO:30529 in Table 3) is shown in a study of
stimulated CLL cells [70].
In general, our results are in accordance with transcriptomic
results, since mRNA expression of genes involved in signal
transduction and transcription was up-regulated after 24 h [12],
[13], [14]. However, a more detailed analysis revealed differences
between the expressions of corresponding genes/proteins. For
example, 14-3-3 proteins t, b/a and e (GO:35308 in Table 1,
GO:50815 and GO:42826 in Table 2) were co-regulated at
proteomic level, but at transcriptomic level their mRNA profiles
differ [14].
A Turning Point after 72 h with Decreased Energy
Requirements
As seen in Figure 4, 48 h was a relatively quiescent time point
with a continuum of down-regulation events that begun at 24 h.
Whereas 72 h was a turning point with two kinds of cellular
events. Firstly, some of the events that occurred at 24 h reoccur at
72 h, like mRNA translation (see clusters 3R and 6R in Figure 3
and ribonucleoprotein complex GO:30529 in Table 3), reflecting
the cell cycle phase in Ramos B cells. Secondly, proteins involved
in hemopoiesis (GO:30097 in Table 1) were down-regulated and
energy production begun to decrease. For example, the down-
regulation of enzymes involved in tricarboxylic acid cycle
(Reactome:1046 in Table S4) and metabolism of oxaloacetate
and carbohydrate (GO:6107, GO:44262 and GO:6096 in Table 1)
indicate decreased metabolism after 72 h of stimulation until the
end of the time course. The result suggests a dual respond at 72 h:
One population of Ramos B cells entered the cell cycle whereas
the other population with decreased metabolism was prevented of
entering the cell cycle but committed to apoptosis. In line with our
result, the ligation of IgM triggers B cells into proliferation and
apoptosis [76], [83], [84], [85]. The proportion of Ramos B cells,
which enter into apoptosis after crosslinking of IgM, depends on
the phase of the cell cycle and the affinity of the anti-IgM [76],
[85]. The down-regulation of genes related to metabolism, cell
growth, cell division and DNA synthesis was seen also at
transcriptomic level late in the time course [12], [13], [14].
Conclusions
The goal of the proteomic analysis of B cells was to identify the
major protein expression effects during the maturation pathway.
Our study revealed co-expression and -regulation of nearly 190
proteins related to the cellular processes and signalling pathways in
the B cell differentiation pathway from early pre-B to terminally
differentiated plasma cell stage. Our data and analysis provide a
new and deeper description of the B cell proteome during
maturation and in response to BCR activation compared to
previous results thereby extending and complementing our
knowledge of B cell ontogeny. We showed the major changes in
functions of co-expressed proteins between the maturation stages
with greatest difference between early pre-B/pre-B and IM-B
stages. In Ramos and U-266 cells, the different combinations of
proteins in Ig secretory machine indicate partly overlapping, but
distinctive systems for Ig processing and transport. Our time
course analysis of Ramos cells upon anti-IgM stimulation exposed
the early regulation of membrane-cytoskeleton –linked proteins
and the activation of many downstream signalling cascades in
24 h, like FAS and cytoskeleton rearrangement. The results
suggest that many proteins known to be important in the early
steps upon BCR stimulation are re-regulated in 24 h. We showed
the 72 h turning point, after which the metabolic processes were
silenced indicating cell death in Ramos B cells.
Additional studies are required to determine the role of the new
protein candidates, such as UBLCP1 in pre-B cells (697, Nalm-1
and Nalm-6) and VAT-1 and MAGE 4 in plasma cells (U-266).
Also, PTMs in cytoskeleton linked proteins, like plastin-2, stathmin
and cofilin-1 should be investigated further, to elucidate the BCR
activation mechanism in detail.
In conclusion, our proteomic and transcriptomic results for anti-
IgM stimulated Ramos cells are in accordance, since specific
cellular events take place in the same time points. But there are
also cases where the mRNA and protein levels differ. The
differences in protein and mRNA expression are widely known
and reported in many comparative studies [86], [87], [88], [89].
Since many cellular processes are regulated at the protein level, as
noticed also in our previous 2D-GE study [15], it is important to
study the expression dynamics directly at proteome level. This
approach provides deeper insights into B cell ontogeny and may
open new avenues for novel therapeutic strategies to treat PID
patients.
Supporting Information
Figure S1 Unsupervised clustering and correlation
analyses of B cell samples on the basis of proteome
profiles. Two-way hierarchical cluster analysis and correlation
matrix of the B cell lines based on protein abundance profiles of
2063 protein spots in relative to internal standard. The degree of
similarity in profiles is shown by colour (scales below figure). Anti-
IgM stimulated Ramos cells clustered into three subgroups
according to time (1–4, 9–24 and 48–120 h) and the nearby time
points correlate strongly. Early pre-B (RS4;11, 380 and REH) and
pre-B cells (697, Nalm-1 and Nalm-6) have positive correlation.
Early pre-B/pre-B and Ramos cells at late time points (48–96 h)
have weak negative correlation. U-266 plasma cell is distinctive
from the other cell types.
(PDF)
Figure S2 Cluster dendrogram of B cell samples on the
basis of proteome profile. The dendrogram shows the distinct
pattern of IM-B Ramos cell samples (right branch) compared to
early pre-B (380, REH and RS4;11), pre-B (697, Nalm-1, Nalm-6)
and U-266 plasma cell samples (left branch). The stimulated and
corresponding control Ramos B samples are clustered in twos
indicating minor anti-IgM induced proteome-wide changes,
except at 24 h (clustered singly) and 96–120 h (clustered two by
two).
(PDF)
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Table S1 B cell lines. List of B cell lines with respective origin,
differentiation stage and Ig chain expression.
(PDF)
Table S2 Proteins in B cell proteome database. List of
identified proteins with respective UniProt accession numbers,
experimental pI and Mr values, number of peptide matches,
intensity and sequence coverage, as well as Mascot scores to show
the reliability of the identifications (p,0.05).
(PDF)
Table S3 Peptides identified from different proteins by
fragment ion analysis. List of identified peptides with Mascot
scores to show the reliability of the identifications (p,0.05).
(PDF)
Table S4 Signalling pathways and identified proteins
involved. List of Reactome, KEGG and BioCarta pathways and
proteins involved with corresponding p-values.
(PDF)
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